| Expression pattern: |
DN |
| Associated gene: |
RBM47, IGF2BP1, FNDC3B mRNA |
| Associated microRNA: |
- |
| Biological function: |
suppresses osteosarcoma proliferation, migration, invasion and tumor growth |
| Molecular mechanism: |
RBM47 binds flanking introns to facilitate circFNDC3B biogenesis, reducing FNDC3B mRNA; circFNDC3B competitively binds IGF2BP1 to reduce FNDC3B mRNA stability |
| Biological pathway or process: |
proliferation (inhibits); migration (inhibits); invasion (inhibits); mRNA stability (inhibits); other pathway/process (other) |
| Detected method: |
Q
|
| Validation methods: |
Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; RT-qPCR; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; RIP (RNA Immunoprecipitation); Actinomycin D / DRB Stability Assay; Transfection; CCK8; EdU Staining; Wound Healing Assay; Transwell Assay; In Vivo Animal Model; Clinical Sample Validation; Survival Analysis; Bioinformatics Analysis |
| Clinical significance: |
may be biomarkers for indicating disease progression and prognosis of OS patients |
| Description: |
circFNDC3B is down-regulated in osteosarcoma and functions as a tumor suppressor, inhibiting OS cell proliferation, migration, invasion and xenograft tumor growth. Mechanistically, RBM47 promotes circFNDC3B biogenesis via binding flanking introns, and circFNDC3B competitively binds IGF2BP1 to reduce FNDC3B mRNA stability, contributing to a circular FNDC3B/FNDC3B mRNA imbalance. |
| Confidence score: |
0.8396 |